Influence of CYP2D6*4 polymorphism on the outcome of treatment with serotonergic drugs. Role of community pharmacy in its optimization

dc.contributor.author	García-Sánchez, Belén
dc.contributor.author	Rodríguez-Arcas, María-Jesús
dc.contributor.author	Ortiz-Sánchez, Juana-María
dc.contributor.author	Conesa-Zamora, Pablo
dc.date.accessioned	2025-11-26T11:45:16Z
dc.date.available	2025-11-26T11:45:16Z
dc.date.issued	2024
dc.identifier.citation	García Sánchez B, Rodríguez Arcas MJ, Ortiz Sánchez JM, Conesa Zamora P. Influencia del polimorfismo del CYP2D6*4 en el resultado del tratamiento con fármacos serotoninérgicos. Papel de la farmacia comunitaria en su optimización. Pharm Care Esp [Internet]. 23 de mayo de 2024 [citado 25 de noviembre de 2025];26. Disponible en: https://www.pharmcareesp.com/index.php/PharmaCARE/article/view/841
dc.identifier.issn	1139-6202
dc.identifier.uri	https://sms.carm.es/ricsmur/handle/123456789/22672
dc.language.iso	eng
dc.publisher	FUNDACION PHARMACEUTICAL CARE ESPANA
dc.rights	Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri	https://creativecommons.org/licenses/by-nc-sa/4.0	*
dc.title	Influence of CYP2D6*4 polymorphism on the outcome of treatment with serotonergic drugs. Role of community pharmacy in its optimization
dc.type	info:eu-repo/semantics/article
dc.relation.publisherversion	https://www.pharmcareesp.com/index.php/PharmaCARE/article/view/841
dc.identifier.doi	10.60103/phc.v26.e841
dc.journal.title	Pharmaceutical Care Espana